STOCK TITAN

Nuwellis Inc Form 4 Filings

NUWE NASDAQ

Every Form 4 that Nuwellis Inc (NUWE) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow NUWE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NUWE filings page.

Rhea-AI Summary

Nuwellis, Inc. reported that director Gregory D. Waller received a grant of 6,744 nonstatutory stock options for common stock. The options have an exercise price of $1.16 per share and expire on April 27, 2036.

According to the filing, these options vest in 12 approximately equal monthly installments starting one month after the grant date, becoming fully vested after one year. Following this award, Waller holds 6,744 derivative securities of this type directly, reflecting a routine compensation-related equity grant rather than an open-market purchase.

Rhea-AI Summary

Nuwellis, Inc. director Emerson J. Martin received a grant of nonstatutory stock options as part of his equity compensation. The award covers 6,744 options to buy Nuwellis common stock at an exercise price of $1.16 per share.

The options vest in 12 approximately equal monthly installments starting one month after the grant date, so they are fully vested after one year. The options expire on April 27, 2036 if not exercised. After this grant, Martin holds 6,744 derivative securities related to Nuwellis common stock directly.

Rhea-AI Summary

Nuwellis, Inc. director Archelle Georgiou Feldshon received a grant of nonstatutory stock options covering 6,744 shares of common stock. The options have an exercise price of $1.16 per share and expire on April 27, 2036.

The award vests in 12 approximately equal monthly installments starting one month after the grant date, so all 6,744 options will be fully vested on the one-year anniversary of the grant. This is a compensation-related equity grant, not an open-market share purchase or sale.

Rhea-AI Summary

Nuwellis, Inc. director David McDonald received a grant of nonstatutory stock options covering 6,744 shares of common stock. The options have an exercise price of $1.16 per share and expire on April 27, 2036. They vest in 12 approximately equal monthly installments over one year.